| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/05/1991 | WO1991013053A1 DERIVATIVE OF β-PHENYLISOSERINE, PREPARATION AND UTILISATION THEREOF |
| 09/05/1991 | WO1991012811A1 Oligonucleotide therapies for modulating the effects of herpesviruses |
| 09/05/1991 | WO1991012810A1 Immunosuppressant |
| 09/05/1991 | WO1991012808A1 Artificial tears |
| 09/05/1991 | WO1991012807A1 Use of vitamin-d analogues in the treatment of acne |
| 09/05/1991 | WO1991012806A1 Compositions and methods of treatment of sympathetically maintained pain |
| 09/05/1991 | WO1991012805A1 Method of treating therapy-resistant schizophrenia with amperozide |
| 09/05/1991 | WO1991012803A1 Hydantoin derivatives for use as hypoglycemic and/or hypolipidemic agents |
| 09/05/1991 | WO1991012802A1 Production and use of porphyrin derivatives and of compositions containing such derivatives |
| 09/05/1991 | WO1991012799A1 Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders |
| 09/05/1991 | WO1991012797A1 Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists |
| 09/05/1991 | WO1991012785A1 Device and method for administration of physostigmine |
| 09/05/1991 | WO1991011435A3 New centrally acting 6,7,8,9-tetrahydro-3h-benz(e)indole heterocyclics |
| 09/05/1991 | WO1991011201A3 Compounds |
| 09/05/1991 | WO1991010427A3 The effect of transglutaminase inhibition on microfilariae development and macrofilariae viability |
| 09/05/1991 | WO1991009593A3 5-ht3 antagonists for treatment of nausea, bradycardia of hypotension associated with myocardial instability |
| 09/05/1991 | DE4006564A1 New use of phosphoric acid ester derivs. - in treatment of skin disorders, esp. neurodermatitis, psoriasis, kaposis sarcoma, acne, eczema and allergies |
| 09/05/1991 | CA2408856A1 Pharmaceutical composition and use for limiting acute or chronic closure of a vascular lumen |
| 09/05/1991 | CA2077258A1 N,n'-disubstituted guanidines and their use as excitatory amino acid antagonists |
| 09/05/1991 | CA2074523A1 Oligonucleotide therapies for modulating the effects of herpesviruses |
| 09/04/1991 | EP0445098A2 Deoxynojirimycin derivatives as antiviral agents |
| 09/04/1991 | EP0445073A1 Benzofurans |
| 09/04/1991 | EP0445062A1 4(1H)Quinolone derivatives |
| 09/04/1991 | EP0445039A1 Pyridylsulfonylurea and pyridylsulfonylthiourea derivatives, process for their preparation and pharmaceutical compositions containing them |
| 09/04/1991 | EP0445026A1 Aminomethylpiperidine derivatives, their process for preparation and the pharmaceutical compositions containing them |
| 09/04/1991 | EP0445021A2 Tris acyl-2",3",4'ethylidene-4",6"-beta-D-glucopyranosides, their production and use in the synthesis of ethylidene-4",6"-beta-D-glucopyranosides of epipodophyllotoxin |
| 09/04/1991 | EP0445013A1 C-cycloalkyl-alkylamines, process for their preparation, their use as therapeutic agents and intermediates for their synthesis |
| 09/04/1991 | EP0444964A1 Milbemycin ether derivatives, their preparation and their anthelmintic uses |
| 09/04/1991 | EP0444945A2 Use of spirocyclic compounds as oxytocin antagonists |
| 09/04/1991 | EP0444931A2 Use of 3-oxygermylpropionic acid to treat and prevent diabetes due to autoimmune diseases |
| 09/04/1991 | EP0444924A1 Fused 7-membered cyclic compound and antipsychotic preparation containing the same |
| 09/04/1991 | EP0444899A2 Catechol derivatives, their physiologically acceptable salts, esters and their use in the treatment of tissue damage induced by lipid peroxidation |
| 09/04/1991 | EP0444891A1 Use of a pyrodextrin hydrolysate for the preparation of a food composition for performing improvement of serum lipid |
| 09/04/1991 | EP0444889A1 Novel synthesis of carbapenem intermediates |
| 09/04/1991 | EP0444888A1 Process for the desilylation of a 4-silyloxy-tetrahydro-pyran-2-one |
| 09/04/1991 | EP0444855A1 Improvements in and relating to (S)-norfluoxetine |
| 09/04/1991 | EP0444854A2 6-Substituted hexahydrobenz[cd]indoles |
| 09/04/1991 | EP0444853A2 Hexahydrobenz[cd]indoles |
| 09/04/1991 | EP0444852A2 Crystalline salt of 4-(di-n-propyl)amino-6-aminocarbonyl-1,3,4,5-tetrahydrobenz[cd]indole |
| 09/04/1991 | EP0444848A1 Process for preparing [1S-[1alpha,2alpha(Z),3alpha,4alpha]]-7-[3-[[[[(1-oxoheptyl)-amino]acetyl]amino]methyl]-7-oxabicyclo-[2.2.1]hept-2-yl]-5-heptenoic acid |
| 09/04/1991 | EP0444844A2 New 15-dehydroxy-16-oxoprostaglandins |
| 09/04/1991 | EP0444829A2 Immunosuppressive compounds |
| 09/04/1991 | EP0444659A2 A pharmaceutical solution comprising derivatives of FK506 |
| 09/04/1991 | EP0444625A1 Omeprazole compositions designed for administration in Rectum |
| 09/04/1991 | EP0444549A1 Imidazopyridazines their production and use |
| 09/04/1991 | EP0444546A1 Hydantoin derivatives for use as hypoglycemic and/or hypolipidemic agents |
| 09/04/1991 | EP0444533A2 Quinoline and pyridine anchors for HMG-CoA reductase inhibitors |
| 09/04/1991 | EP0444532A1 Phosphorus-containing HMG-CoA reductase inhibitors, new intermediates and method |
| 09/04/1991 | EP0444482A2 Oxetanones |
| 09/04/1991 | EP0444451A2 3-Arylcarbonyl-1H-indoles useful as therapeutic agents |
| 09/04/1991 | EP0444424A2 Bile acid unsaturated derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
| 09/04/1991 | EP0444208A1 Lipid a monosaccharide analog |
| 09/04/1991 | EP0444194A1 Agent for thermotherapy |
| 09/04/1991 | EP0444033A1 Topical cosmetic and pharmaceutical preparation |
| 09/04/1991 | EP0202276B1 Composition for the treatment of psoriasis |
| 09/04/1991 | CN1054250A 吲哚衍生物 Indole derivatives |
| 09/04/1991 | CN1054249A Sulfoneanilide derivative and application of same in medicine |
| 09/04/1991 | CN1013769B Method for preparation of improvement leukotriene antagonists |
| 09/03/1991 | WO1991012792A1 Method and product for promoting hair growth and treating skin conditions |
| 09/03/1991 | US5045567 Propanolamine derivatives having anti-diabetic effects |
| 09/03/1991 | US5045564 Calcium channel antagonists |
| 09/03/1991 | US5045562 Antilipemic and antiarteriosclerotic |
| 09/03/1991 | US5045559 Esters of Pyroglutamic Acid |
| 09/03/1991 | US5045558 Aromatase inhibitors, prevention of estrogen biosynthesis, treatment of breast cancer |
| 09/03/1991 | US5045556 Aralkyl-4H-1,2,4-triazole derivatives |
| 09/03/1991 | US5045553 Isopropyl Methyl 2-Cyano-4-/m-Nitrophenyl/-6-Methyl-1,4-Dihydro-3,5-Pyridinedicarboxylate, Oleic Acid, Ethanol |
| 09/03/1991 | US5045552 Benzimidazole sulfoxides |
| 09/03/1991 | US5045551 Acetylenes disubstituted with a heteroaromatic group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
| 09/03/1991 | US5045549 Bactericides |
| 09/03/1991 | US5045548 Quinolyl methoxy compounds and their use as antiasthmatic agents |
| 09/03/1991 | US5045547 Leukotriene-inhibiting substituted (quinolin-2-yl-methoxy)phenyl-N,N'-sulphonylureas and use thereas |
| 09/03/1991 | US5045546 8-azabicyclo[3.2.1]octylalkylthiazolidines |
| 09/03/1991 | US5045545 [(Imidazol-4(and 5)-yl)methyl] tetracyclic ketones having 5-HT3 antagonist activity |
| 09/03/1991 | US5045544 N'-alkyl-spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors |
| 09/03/1991 | US5045543 Treatment of cancer with high probability of metastasis |
| 09/03/1991 | US5045541 Immunodeficiency disorders |
| 09/03/1991 | US5045538 Promoting protein synthesis in skeletal muscle systems |
| 09/03/1991 | US5045534 Daunorubicin Derivatives |
| 09/03/1991 | US5045532 Inner esters of gangliosides with analgesic-antiinflammatory activity |
| 09/03/1991 | US5045530 Conprising a micelle or a vesicle of a cationic teniside based on a hydrophobic alkyl-substituted pyridinium compound and a hydrophobic drug; drug delivery; skin disorders |
| 09/03/1991 | US5045457 Novel compounds |
| 09/03/1991 | US5045324 Pasty dialyzing composition for perfusing artificial kidney systems and process for preparing same |
| 09/03/1991 | US5045321 Antiulcer compound lansoprazole or omeprazole with magnesium and/or calcium salt; tablets or granules |
| 09/03/1991 | US5045320 Large multivalent immunogen |
| 09/03/1991 | US5045306 N-alkylamides of D,L and L(-)-carnitine having antibacterial activity, process for their preparation and pharmaceutical and cosmetic compositions containing same |
| 09/03/1991 | US5045104 Bactericides, algicides, fungicides |
| 09/03/1991 | CA2288413A1 Medicament pack for use in treating respiratory disorders |
| 09/03/1991 | CA2037357A1 Methods for using spirocyclic oxytocin antagonists |
| 09/03/1991 | CA2037287A1 Spirocyclic oxytocin antagonists |
| 09/03/1991 | CA2037189A1 Pyridylsulfonylurea and pyridulsulfonylthiourea derivatives; process for preparing the same and pharmaceutical compositions containing them |
| 09/03/1991 | CA2036407A1 Phosphorus-containing hmg-coa reductase inhibitors, new intermediates and method |
| 09/03/1991 | CA1288547C 1-(3-mercapto-2-methylpropanoyl) prolyl amino acid derivatives and salts thereof, processes for their preparation and pharmaceutical compositions containing such compounds |
| 09/03/1991 | CA1288436C Phenylquinolinecarboxylic acids and derivatives as antitumor agents |
| 09/03/1991 | CA1288435C Substituted hexahydroarylquinolizines |
| 09/03/1991 | CA1288432C Oxadiazole-alkyl-purine derivatives |
| 09/03/1991 | CA1288431C N9-cyclopentyl-substituted adenine derivatives |
| 09/03/1991 | CA1288430C 5-substituted octahydroindolizine analgesics compounds and 7-keto intermediates |
| 09/03/1991 | CA1288428C Thiazepine compounds |
| 09/03/1991 | CA1288426C Process for producing 13-substituted milbemycin derivatives |
| 09/03/1991 | CA1288424C Inclusion complex of 7-isopropoxy-isoflavon formed with cyclodextrin, the preparation thereof and pharmaceutical compositions containing these compounds as active ingredient |